Suppr超能文献

更优佐剂,成就更优疫苗:佐剂递送系统、修饰及佐剂-抗原共递送的进展

Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant-Antigen Codelivery.

作者信息

Wang Zhi-Biao, Xu Jing

机构信息

National Vaccine and Serum Institute, Beijing Economic-Technological Development Area, Beijing 101111, China.

出版信息

Vaccines (Basel). 2020 Mar 13;8(1):128. doi: 10.3390/vaccines8010128.

Abstract

Traditional aluminum adjuvants can trigger strong humoral immunity but weak cellular immunity, limiting their application in some vaccines. Currently, various immunomodulators and delivery carriers are used as adjuvants, and the mechanisms of action of some of these adjuvants are clear. However, customizing targets of adjuvant action (cellular or humoral immunity) and action intensity (enhancement or inhibition) according to different antigens selected is time-consuming. Here, we review the adjuvant effects of some delivery systems and immune stimulants. In addition, to improve the safety, effectiveness, and accessibility of adjuvants, new trends in adjuvant development and their modification strategies are discussed.

摘要

传统铝佐剂可引发强烈的体液免疫,但细胞免疫较弱,这限制了它们在某些疫苗中的应用。目前,各种免疫调节剂和递送载体被用作佐剂,其中一些佐剂的作用机制已明确。然而,根据所选不同抗原定制佐剂作用的靶点(细胞免疫或体液免疫)和作用强度(增强或抑制)耗时较长。在此,我们综述了一些递送系统和免疫刺激剂的佐剂效应。此外,为提高佐剂的安全性、有效性和可及性,还讨论了佐剂开发的新趋势及其修饰策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验